Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1490, 2005-01, pp. : 15-15
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Greater long-term CV risk reduction with intensive insulin therapy
Inpharma, Vol. 1, Iss. 1520, 2006-01 ,pp. :
Access to resources
Recommend
Insulin therapy decreases long-term costs in type 2 DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 426, 2003-01 ,pp. :
Insulin glargine superior long-term therapy for type 2 DM in Europe
Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. :
Insulin glargine superior long-term therapy in type 2 DM in Europe
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 462, 2004-01 ,pp. :
Impact of complications on long-term survival after resection of intrahepatic cholangiocarcinoma
Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. :